These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33892777)

  • 21. Psychedelic microdosing benefits and challenges: an empirical codebook.
    Anderson T; Petranker R; Christopher A; Rosenbaum D; Weissman C; Dinh-Williams LA; Hui K; Hapke E
    Harm Reduct J; 2019 Jul; 16(1):43. PubMed ID: 31288862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motives and Side-Effects of Microdosing With Psychedelics Among Users.
    Hutten NRPW; Mason NL; Dolder PC; Kuypers KPC
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):426-434. PubMed ID: 31152167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.
    Kaypak AC; Raz A
    Transcult Psychiatry; 2022 Oct; 59(5):665-674. PubMed ID: 36031848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta-analysis of randomised controlled trials in healthy volunteers.
    Li H; Zhong Y; Yang S; Wang J; Li X; Xu J; Gao H; Chen G
    Hum Psychopharmacol; 2022 May; 37(3):e2825. PubMed ID: 34739739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
    Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
    Elife; 2018 Oct; 7():. PubMed ID: 30355445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the 5-HT
    Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
    J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients.
    Wells A; Muthukumaraswamy APS; Morunga E; Evans W; Cavadino A; Bansal M; Lawrence NJ; Ashley A; Hoeh NR; Sundram F; Applebaum AJ; Parkinson H; Reynolds L
    Pilot Feasibility Stud; 2024 Feb; 10(1):29. PubMed ID: 38347582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects.
    Mueller F; Lenz C; Dolder PC; Harder S; Schmid Y; Lang UE; Liechti ME; Borgwardt S
    Transl Psychiatry; 2017 Apr; 7(4):e1084. PubMed ID: 28375205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity.
    Glazer J; Murray CH; Nusslock R; Lee R; de Wit H
    Neuropsychopharmacology; 2023 Jan; 48(2):418-426. PubMed ID: 36284231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greater subjective effects of a low dose of LSD in participants with depressed mood.
    Molla H; Lee R; Tare I; de Wit H
    Neuropsychopharmacology; 2024 Apr; 49(5):774-781. PubMed ID: 38042914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity.
    Bershad AK; Preller KH; Lee R; Keedy S; Wren-Jarvis J; Bremmer MP; de Wit H
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Apr; 5(4):461-467. PubMed ID: 32033922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.
    Yanakieva S; Polychroni N; Family N; Williams LTJ; Luke DP; Terhune DB
    Psychopharmacology (Berl); 2019 Apr; 236(4):1159-1170. PubMed ID: 30478716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic potential of microdosing psychedelics in depression.
    Kuypers KPC
    Ther Adv Psychopharmacol; 2020; 10():2045125320950567. PubMed ID: 32922736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility.
    Wießner I; Olivieri R; Falchi M; Palhano-Fontes F; Oliveira Maia L; Feilding A; B Araujo D; Ribeiro S; Tófoli LF
    Eur Neuropsychopharmacol; 2022 May; 58():7-19. PubMed ID: 35158230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting.
    Prochazkova L; Lippelt DP; Colzato LS; Kuchar M; Sjoerds Z; Hommel B
    Psychopharmacology (Berl); 2018 Dec; 235(12):3401-3413. PubMed ID: 30357434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microdosing with classical psychedelics: Research trajectories and practical considerations.
    Wong A; Raz A
    Transcult Psychiatry; 2022 Oct; 59(5):675-690. PubMed ID: 36317302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.
    Lo DF; Zia H; Rajkumar P; Thakur A; O'Donnell H
    Prim Care Companion CNS Disord; 2024 Jan; 26(1):. PubMed ID: 38228068
    [No Abstract]   [Full Text] [Related]  

  • 38. The paradoxical psychological effects of lysergic acid diethylamide (LSD).
    Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ
    Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking.
    Wießner I; Falchi M; Maia LO; Daldegan-Bueno D; Palhano-Fontes F; Mason NL; Ramaekers JG; Gross ME; Schooler JW; Feilding A; Ribeiro S; Araujo DB; Tófoli LF
    J Psychopharmacol; 2022 Mar; 36(3):348-359. PubMed ID: 35105186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
    Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
    J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.